Back to search
FDAFDA · Food and drugs·Recall number D-0854-2021

Valproic Acid Oral Solution, USP, 500 mg/10 mL, 100 10 mL unit dose cups per case, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217 Case NDC#: 60687-262-56; Individual Dose NDC: 60687-262-42

Published October 6, 2021 · Recall initiated: September 15, 2021

Summary

FDA records drug Class II recall D-0854-2021, published October 6, 2021 and initiated September 15, 2021. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 548 ccases; Lot: Lot 1000082; Exp 06/30/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
American Health Packaging
Distributor
Nationwide USA
Lot
Lot 1000082; Exp 06/30/2022
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Valproic Acid Oral Solution, USP, 500 mg/10 mL, 100 10 mL unit dose cups per case, Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217 Case NDC#: 60687-262-56; Individual Dose NDC: 60687-262-42 recalled?

Yes. FDA published recall D-0854-2021 on October 6, 2021. Reported hazard: CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.

What should I do if I have this product?

Voluntary: Firm initiated · Letter